This message was sent to ##Email##
|
|
|
Save the date for the 2016 Spring Forum being held April 21-22, 2016 at the Gaylord Palms in Orlando. Click here to visit the conference website.
Fast Company
Researchers in Switzerland have been studying the effect of genes on the aging process and have published their results in the journal Nature Communications. Of the 40,000 genes they studied, they found 30 that allow a variety of animals, including roundworms, zebrafish, and mice, to stay healthier and live longer. But these scientists focused specifically on genes that are also found in human beings, so the next step in their project is to see if these genes also have an impact on us as well.
READ MORE
NPR
Global warming isn't the only vexing issue the world wrestled with this week.
While delegates gathered in Paris to discuss climate change, the International Summit on Human Gene Editing convened in Washington, D.C., to debate another conundrum: How far should scientists go when editing human DNA?
READ MORE
AIDS Healthcare Foundation
Founded in 1987, AIDS Healthcare Foundation is the largest specialized provider of HIV/AIDS medical care in the nation. Our mission is to provide cutting edge medicine and advocacy, regardless of ability to pay. Through our healthcare centers, pharmacies, health plan, research and other activities, AHF provides access to the latest HIV treatments for all who need them.
READ MORE
Medical Xpress
Genes that act as brakes to stop the development of an aggressive form of leukaemia have been identified by researchers.
Their findings offer fresh insights into how to tackle the disease and could lead to new therapies that prevent relapses.
READ MORE
The New York Times
In 2013, an obese man went to Hvidovre Hospital in Denmark to have his stomach stapled. All in all, it was ordinary bariatric surgery — with one big exception. A week before the operation, the man provided a sperm sample to Danish scientists. A week after the procedure, he did so again. A year later, he donated a third sample. Scientists were investigating a tantalizing but controversial hypothesis: that a man’s experiences can alter his sperm, and that those changes in turn may alter his children.
READ MORE
Promoted by
|
|
|
 |
| BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE |
CNBC
There may be a big advantage to treating people with personalized medicine — drugs and treatments tailored to an individual's genetic profile — but improved health outcomes for them will come at a big cost.
That's because it is very costly to screen patients for such tailored treatments and to produce medicine that targets individuals or narrow groups of patients.
READ MORE
HIT Consultant
SAP SE announced SAP Foundation for Health and the SAP Medical Research Insights solutions built on the SAP HANA platform to realize the full potential of personalized medicine.
By unlocking patient data and uncovering insights in real time, the new solutions reveal the value of patient data, from biomedical data to EMRs to clinical trials. They facilitate data integration and provide real-time analysis and reporting that together lead to improved personalized medicine and patient care.
READ MORE
 |
|
INSIGHTEC’s MRgFUS technology - focused ultrasound waves, guided by magnetic resonance imaging - completely transforms the world of medicine by offering a ground-breaking, non-invasive therapy platform that reduces the need for invasive surgery.
|
|
Medical Xpress
Technological advances ranging from gene editing to next-generation sequencing offer unprecedented access to the human genome and promise to reshape the diagnosis and treatment of epilepsy. Four studies presented at the American Epilepsy Society's 69th Annual Meeting demonstrate how these innovative technologies are being used to identify and manipulate genes linked to epilepsy.
READ MORE
Medscape
Transplantation of cells from umbilical cords along with autologous bone marrow stem cells may represent a promising new approach for treating patients with established type 1 diabetes, a new proof-of-concept study suggests.
One-year findings from an open-label randomized trial of 42 patients who received either the combined transplanted cells or standard care were presented at the World Diabetes Congress 2015 by Xiumin Xu, director of China-USA Collaborative Human Cell Transplant Program at the Diabetes Research Institute at the University of Miami, Coral Gables, Florida, and were simultaneously published in Diabetes Care.
READ MORE
Medical Xpress
A combination of adult stem cells and parathyroid hormone significantly increased new bone formation in laboratory animals and may speed the healing process for human bone fractures caused by osteoporosis, a new study shows. The study is published online by Molecular Therapy, a peer-reviewed journal in the Nature Publishing Group.
READ MORE
| EMERGING MEDICAL TECHNOLOGIES |
The Huffingotn Post
Imagine 3-D printers that could produce healthy new organs, human tissue and artificial limbs, just like your office printer cranks out paper reports. While it’s not nearly that advanced yet, 3-D technology is making strides in surgery, medicine and pharmacology. See how 3-D printing is paving the way for future breakthroughs — and helping patients now.
READ MORE
Health Data Management
Not so long ago, telemedicine vendors had proprietary standards to connect point-to-point devices via the Internet to conduct a telehealth session. Now, there are open connectivity standards that eliminate additional steps to launch a session, making use of telemedicine simpler. There remain significant differences among vendors in the architecture of telemedicine systems, says Steve McGraw, CEO at telemedicine vendor Reach Health, but proprietary standards for network connections are going away fast.
READ MORE
By Scott E. Rupp
Sens. Cory Gardner and Gary Peters have introduced a new bill to expand access to healthcare — especially in rural and underserved areas that would allow Medicare to cover additional telehealth services. The bill, known as the Telehealth Innovation and Improvement Act, would allow Medicare to expand its coverage of telehealth services, changing what the Senators call a "poor industry standard" that discourages innovation and restricts access to specialized services.
READ MORE
| ACCOUNTABLE CARE ORGANIZATIONS |
FierceHealthcare
An accountable care organization operated by a Wisconsin health system and UnitedHealthcare performed above care quality goals in the first year of the three-year partnership, due in large part to improved care coordination and data-sharing, according to a new report from UnitedHealthcare.
Integrated Health Network and UnitedHealthcare established their ACO in 2013, and in 2014 it yielded results that were a substantial improvement over 2012.
READ MORE
Forbes
The U.S. hospital industry is back, thanks to the Affordable Care Act, with liquidity levels so improved these health facilities should weather coming shifts in government payments or employer moves to coordinate care toward outpatient services.
A new report from Fitch Ratings shows the outlook for nonprofit hospitals, which makeup the bulk of the nation’s inpatient health facilities, have built a “solid financial cushion to absorb potential operating volatility” in 2016.
READ MORE
| FDA: NEW TREATMENTS AND TECHNOLOGY |
The Boston Globe
Newton, Massachusetts-based Alcresta Pharmaceuticals said it has received federal approval to market its flagship product, Relizorb, which helps people who use feeding tubes better digest their food.
Relizorb is a “digestive cartridge” that mimics the enzymes usually produced by the pancreas, helping to break down fats and allowing patients to get more nutrition from feeding tube formula.
READ MORE
ModernMedicine
FDA has approved elotuzumab as combination therapy with lenalidomide and dexamethasone in people with multiple myeloma who have received one to three prior medications. Multiple myeloma is a hematologic cancer that forms in plasma cells, a type of white blood cell found in the bone marrow that produces antibodies to help fight infections.
The Huffington Post
Even if insured how much can we depend on private health insurance any more? The bottom line — less and less as it continues to degrade after almost six years under the Affordable Care Act. Its coverage continues to degrade even as its costs become increasingly unaffordable.
READ MORE
Forbes
For years, we’ve heard from Obamacare’s supporters that the law has been a success, because, they say, it has provided more people with health insurance, and slowed the growth rate of health spending. Well, the returns are in.
READ MORE
|
Seattle Genetics Demonstrates Commitment to Improve Hodgkin Lymphoma (HL) Treatment Paradigm Through ADCETRIS® Data Presentations at ASH 2015. Click here for more information.
|
Check out JMCM’s new website at www.jmcmpub.org
|
Seattle Genetics Announces FDA Regular Approval of ADCETRIS® for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression. Click here to view more information. |
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
|
Sandoz, a Novartis company, announced today that Zarxio(TM) (filgrastim-sndz) is now available in the United States. Zarxio is the first biosimilar approved by the US Food and Drug Administration (FDA) and the first to launch in the US. Please click here for more information.
. |
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|